Abstract
Background/Objectives:
Coffee consumption has been postulated to decrease the risk of diabetes mellitus type II. The long-term effects of coffee consumption on the metabolic syndrome (MS) and its components are unknown. This study investigated the relationship of long-term coffee consumption between the age of 27 and 36 years with the prevalence of the MS at the age of 36 years.
Subject/Methods:
Data on coffee consumption and the MS components were derived from a healthy sample of 174 men and 194 women followed up from the age of 27 years onwards. Data analysis was performed with the use of generalized estimating equations and regression analysis.
Results:
At the age of 36 years, the prevalence of the MS was 10.1%. The growth of coffee consumption did not differ significantly between subjects with or without the MS or its components. Regression analyses showed that one cup day−1 higher coffee consumption was related to 0.11 mm Hg lower mean arterial blood pressure (P=0.03), 0.02 mg 100 ml−1 higher triglyceride level (P=0.57), 0.04 mg 100 ml−1 higher high-density lipoprotein cholesterol level (P=0.35), 0.09% higher HbA1c (P=0.12) and 0.02 cm larger waist circumference (P=0.57). After adjustment for physical activity, energy intake, smoking behaviour and alcohol consumption, none of the relationships between coffee consumption and the MS or its components was significant.
Conclusions:
Coffee consumption is not associated with the MS or its components in a healthy sample followed up for 9 years.
Similar content being viewed by others
References
Agardh EE, Carlsson S, Ahlbom A, Efendic S, Grill V, Hammar N et al. (2004). Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 255, 645–652.
Ainsworth BE, Haskell WL, Leon AS, Jacobs Jr DR, Montoye HJ, Sallis JF et al. (1993). Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sport Exerc 25, 71–80.
Arnlov J, Vessby B, Riserus U (2004). Coffee consumption and insulin sensitivity. JAMA 291, 1199–1201.
Astrup A, Andersen T, Christensen NJ, Bülow J, Madsen J, Breum L et al. (1990). Impaired glucose-induced thermogenesis and arterial norepinephrine response persist after weight reduction in obese humans. Am J Clin Nutr 51, 331–337.
Astrup A, Breum L, Toubro S, Hein P, Quaade F (1992). The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on a energy restricted diet. A double blind trial. Int J Obes Relat Metab Disord 16, 269–277.
Bernaards CM, Twisk JW, van Mechelen W, Snel J, Kemper HC (2004). Comparison between self-report and a dipstick method (NicCheck1) to assess nicotine intake. Eur Addict Res 10, 163–167.
Bidel S, Hu G, Sundvall J, Karpio J, Tuemilehto J (2006). Effects of coffee consumption on glucose tolerance, serum glucose and insulin levels—a cross-sectional analysis. Horm Metab Res 38, 38–43.
Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J (2007). Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur J Clin Nutr, 1–8 [Epub ahead of print].
Bucala R, Vlassara H (1995). Advanced glycosylation end products in diabetic renal and vascular disease. Am J Kidney Dis 26, 875–888.
Davidson MB, Schriger DL, Peters AL, Lorber B (1999). Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281, 1203–1210.
de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N (2004). Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 110, 2494–2497.
Dobbelsteyn CJ, Joffres MR, MacLean DR, Flowerdew G (2001). A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes Relat Metab Disord 25, 652–661.
Ferreira I, Henry RM, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD (2005a). The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med 165, 875–882.
Ferreira I, Twisk JW, van MW, Kemper HC, Stehouwer CD (2005b). Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: determinants of the metabolic syndrome in young adults: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med 165, 42–48.
Ford ES (2005). Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 28, 2745–2749.
Ford ES, Giles WH, Dietz WH (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356–359.
Greenberg JA, Axen KV, Schnoll R, Boozer CN (2005). Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes (Lond) 29, 1121–1129.
Greenberg JA, Boozer CN, Geliebter A (2006). Coffee, diabetes, and weight control. Am J Clin Nutr 84, 682–693.
Grundy SM, Brewer Jr HB., Cleeman JI, Smith Jr SC., Lenfant C (2004). Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24, e13–e18.
Han TS, van Leer EM, Seidell JC, Lean ME (1995). Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311, 1401–1405.
Hino A, Adachi H, Enomoto M, Furuki K, Shigetoh Y, Ohtsuka M et al. (2007). Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract 76, 383–389.
Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J (2006). Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. Int J Obes (Lond) 30, 1742–1749.
Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24, 683–689.
Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ (2001). Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 153, 353–362.
Jee SH, He J, Whelton PK, Suh I, Klag MJ (1999). The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 33, 647–652.
Koppes LL, Twisk JW, Snel J, van Mechelen W, Kemper HC (2000). Blood cholesterol levels of 32-year-old alcohol consumers are better than of nonconsumers. Pharmacol Biochem Behav 66, 163–167.
Lopez-Garcia E, van Dam RM, Rajpathak S, Willett WC, Manson JE, Hu FB (2006a). Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr 83, 674–680.
Lopez-Garcia E, van Dam RM, Willet WC, Rimm EB, Manson JE, Stampfer MJ et al. (2006b). Coffee consumption and coronary heart disease in men and women. A prospective cohort study. Circulation 113, 2045–2053.
Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM (2005). Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens 23, 921–928.
Pereira MA, Parker ED, Folsom AR (2006). Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 166, 1311–1316.
Rosengren A, Dotevall A, Wilhelmsen L, Thelle D, Johansson S (2004). Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study. J Intern Med 255, 89–95.
Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ et al. (2004). Coffee consumption and risk for type 2 diabetes mellitus. Ann.Intern Med 140, 1–8.
Schaefer B (2004). Coffee consumption and type 2 diabetes mellitus. Ann Intern Med 141, 321–324.
Spriet LL, MacLean DA, Dyck DJ, Hultman E, Cederblad G, Graham TE (1992). Caffeine ingestion and muscle metabolism during prolonged exercise in humans. Am J Physiol 262, E891–E898.
Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P (2004). Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291, 1213–1219.
Twisk JWR (2003). Applied Longitudinal Data Analysis for Epidemiology: a Practical Guide. Cambridge University Press: Cambridge, England.
van Dam RM, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ (2004). Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia 47, 2152–2159.
van Dam RM, Feskens EJ (2002). Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360, 1477–1478.
van Dam RM, Hu FB (2005). Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294, 97–104.
van Dam RM, Willett WC, Manson JE, Hu FB (2006). Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 29, 398–403.
van Soeren MH, Graham TE (1998). Effect of caffeine on metabolism, exercise endurance, and catecholamine responses after withdrawal. J Appl Physiol 85, 1493–1501.
Wannamethee SG, Shaper AG, Lennon L, Morris RW (2005). Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165, 2644–2650.
Wolffenbuttel BH, Girdano D, Founds HW, Bucala R (1996). Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet 347, 513–515.
Wu T, Willett WC, Hankinson SE, Giovannucci E (2005). Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 28, 1390–1396.
Zock PL, Katan MB, Merkus MP, van DM, Harryvan JL (1990). Effect of a lipid-rich fraction from boiled coffee on serum cholesterol. Lancet 335, 1235–1237.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guarantors: JWR Twisk and MT Driessen.
Contributors: MTD contributed to the manuscript and data analysis; LLJK contributed to the manuscript, study design, data collection and project planning; LV contributed to the manuscript and data analysis; DS contributed to the manuscript and data collection; JWRT contributed to the manuscript, study design, data analysis and coordinated the project.
Rights and permissions
About this article
Cite this article
Driessen, M., Koppes, L., Veldhuis, L. et al. Coffee consumption is not related to the metabolic syndrome at the age of 36 years: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Nutr 63, 536–542 (2009). https://doi.org/10.1038/ejcn.2008.6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2008.6
- Springer Nature Limited
Keywords
This article is cited by
-
Biomarkers of the metabolic syndrome: influence of selected foodstuffs, containing bioactive components
Phytochemistry Reviews (2018)
-
Regularly consuming a green/roasted coffee blend reduces the risk of metabolic syndrome
European Journal of Nutrition (2018)
-
Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study
European Journal of Nutrition (2015)